GlassScriptPhysician profile
Janice L Randel
NPI 1023096963
$3,013.78
in general payments reported to CMS, 2019-2025
18 companies · $449 in 2025
The $449 reported for 2025 was more than what 91% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $616 · 2022: $452 · 2023: $577 · 2024: $920 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $347.71 | 2021-2023 | Austedo Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $282.54 | 2022-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $242.82 | 2022-2024 | |
| Genzyme Corporation | $231.76 | 2023 | |
| Abbvie INC. | $226.25 | 2022-2024 | |
| Corcept Therapeutics | $221.63 | 2024 | Korlym |
| Lilly USA, LLC | $199.98 | 2023-2024 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.31 | 2021-2022 | |
| Esperion Therapeutics, INC. | $124.99 | 2021 | |
| Abbott Laboratories | $124.98 | 2024 | Freestyle Libre 3 |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $124.98 | 2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $122.74 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.35 | 2025 | Gattex |
| Rhythm Pharmaceuticals, INC. | $113.06 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $112.45 | 2024 | Tezspire |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $111.19 | 2025 | |
| Dexcom, INC. | $79.31 | 2022 | |
| Boston Scientific Corporation | $36.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Randel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.